Skip to main content

MicroRNA146a overexpression alleviates intestinal ischemia/reperfusioninduced acute lung injury in mice

Buy Article:

$42.00 + tax (Refund Policy)

Previous studies have shown that microRNAs (miRs), such as miR146a play an important role in the pathogenesis of intestinal ischemia/reperfusion (I/R)induced injury; however, the role of miR146a in intestinal I/Rinduced acute lung injury has not been elucidated. An intestinal I/Rinduced injury mouse model was established in the present study by clamping the superior mesenteric artery and expression levels of miR146a in intestinal and lung tissue samples were evaluated using reverse transcriptionquantitative PCR (RTqPCR). Intestinal and lung histopathological characteristics in mice with intestinal I/Rinduced injury were assessed by hematoxylin and eosin staining, and mRNA and protein expression levels in intestinal and lung tissue samples were evaluated using RTqPCR and western blotting, respectively. miR146a expression was significantly downregulated in the intestinal and lung tissue samples of mice with intestinal I/Rinduced injury. Intestinal I/R injuryinduced histopathological changes in the lung and intestines, and pulmonary edema in mice transduced with an adenoviral miR146aoverexpression vector (the miR146a overexpression group) were alleviated. mRNA expression levels of TNFα, IL1β, IFNγ and TGFβ1, and protein expression levels of TNF receptorassociated factor 6, phosphorylatedp65 NFκB, cleaved caspase3 and cleaved caspase9 in lung and intestinal tissue samples were downregulated in I/RmiR146aoverexpressing mice, compared with those from the I/Rnegative control group. Thus, the present study identified that pretreatment with the miR146a overexpression vector alleviated intestinal I/Rinduced acute lung injury in mice.

Document Type: Research Article

Affiliations: 1: Department of Anesthesiology, Shenzhen Maternity and Child Healthcare Hospital, Southern Medical University, Shenzhen, Guangdong 518028, P.R. China 2: Department of Anesthesiology, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei 441000, P.R. China 3: Department of Food Safety, Market Supervision Administration of Shenzhen Municipality, Shenzhen, Guangdong 518040, P.R. China

Publication date: 01 January 2021

More about this publication?
  • Experimental and Therapeutic Medicine aims to ensure the expedient publication, in both print and electronic format, of studies relating to biology, gene therapy, infectious disease, microbiology, molecular cardiology and molecular surgery. The journal welcomes studies pertaining to all aspects of molecular medicine, and studies relating to in vitro or in vivo experimental model systems relevant to the mechanisms of disease are also included.

    All materials submitted to this journal undergo the appropriate review via referees who are experts in this field. All materials submitted follow international guidelines with regard to approval of experiments on humans and animals.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Information for Advertisers
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content